Tim Higenbottam

Tim Higenbottam

Company: Akari Therapeutics

Job title: Professor


Clinical Impacts of Controlling Dysregulation of the Terminal Complement Pathway and LTB4 3:30 pm

Role of complement dysregulation in a wide range of diseases Learnings from COVID-19 The future role of complement and LTB4 inhibition in chronic diseasesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.